Advanced circulatory support: artificial heart use in patients with heart failure / Suporte circulatório avançado: uso do coração artificial em pacientes com Insuficiência cardíaca

Luiza Miranda Marinho de Paula, Bruna Xisto Mesquita de Oliveira, Eduarda Viana Maia Sutana, Eduardo Paulo Fonseca Silva, Flávia Ferreira Cassiano, Gabriela Bussad Pires, Larissa Caroline Barbosa, Lucas Magalhães Claros Sossi, Marcos Felipe Calais da Silva, Abner Fernandes da Silva


Objectives: To analyze recent clinical trials about mechanical circulatory support and other adjuvant therapies for the treatment of heart failure. Methods: Articles were selected from the Pubmed and Embase databases published between the years 2015 and 2020, randomized controlled trial or not. The descriptors used were: assisted circulation AND artificial heart AND heart failure, and the descriptor artificial heart was not used for research at EMBASE with 2 articles as results.  And 40 at PubMed with the filters: Controlled Clinical Trial, published in the last 5 years, Humans. Results: Several therapies have been proposed as management alternatives for critically ill patients with heart failure. Among them, we can highlight the HeartMate III implant, which has been shown to have fewer adverse effects compared to HeartMate II; the implantation of an atrial bypass device, which has been shown to decrease the pressure of pulmonary artery occlusion in 1 month compared to the control group, but has shown no long-term effects; and the use of mesenchymal precursor cells, which has not been shown to be significantly effective. Final considerations: It is suggested to carry out further studies to improve the indication criteria, making it possible to allocate resources in hospitalized patients.


Circulatory Failure, Cardiac failure, Heart-Assist Devices

Full Text:



ALLEN LA, et al. Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. JAMA Intern Med, 2018; 178(4): 520-529.

COWGER, JA et al. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients. J Heart Lung Transplant, 2018; 37(1):15-24.

DE CARVALHO A, et al. Avaliação do risco de viés de ensaios clínicos randomizados pela ferramenta da colaboração Cochrane. Diagn Tratamento, 2013; 18(1): 38-44.

DESAI SR, et al. Advances in left ventricular assist devices and mechanical circulatory support. Journal of cardiothoracic and vascular anesthesia, 2018; 32(3): 1193-1213.

EL-JAWAHRI A, et al. Randomized, Controlled Trial of an Advance Care Planning Video Decision Support Tool for Patients With Advanced Heart Failure. Circulation, 2016; 134(1): 52-60.

FELDMAN DS, et al. The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory Support. ASAIO Journal, 2018; 64(3):301-308.

FELDMAN T, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I). Circ Heart Fail, 2016; 9(7): 364-375.

FELDMAN T, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation, 2018; 137(4): 364-375.

GALVÃO TF, et al. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiologia e Serviços de Saúde, 2015; 24:335-342.

GOLDSTEIN DJ, et al. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant, 2018; 37(1): 7-14.

HEATLEY G, et al. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. J Heart Lung Transplant, 2016; 35(4): 528-36.

JUNG MH, et al. Relation Between Pressure and Volume Unloading During Ramp Testing in Patients Supported with a Continuous-Flow Left Ventricular Assist Device. ASAIO J, 2015; 61(3): 307-312.

KEMP, CD; CONTE, JV. The pathophysiology of heart failure. Cardiovascular Pathology; 21(5), 365–371, 2012

KOSTICK KM, et al. A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial). J Card Fail, 2018; 24(10): 661-671.

LOYAGA-RENDON RY, et al. Duration of Heart Failure Is an Important Predictor of Outcomes After Mechanical Circulatory Support. Circ Heart Fail, 2015; 8(5): 953-959.

MCILVENNAN CK, et al. Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial. JACC Heart Fail, 2018; 6(11): 904-913.

MEHRA MR, et al. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med, 2019; 380:1618-1627.

MEHRA MR, et al. A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant, 2018; 37(11):1281-1284.

MEHRA MR, et al. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation, 2018; 138(18):1923-1934.

MEHRA MR, et al. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med, 2018; 378(15):1386-1395.

METZGER M, et al. A randomized controlled pilot trial to improve advance care planning for LVAD patients and their surrogates. Heart Lung, 2016; 45(3):186-92.

ROHDE LEP, et al. Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arq Bras Cardiol., 2018; 111(3): 436-539.

ROGERS JG, et al. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. N Engl J Med, 2017; 376(5): 451-460.

ROGERS JG, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Design and rationale of the ROADMAP clinical trial. American Heart Journal, 2015; 169(2): 205–210.

SHAH SJ, et al. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. JAMA Cardiology, 2018; 3(10): 968-977.

URIEL N, et al. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation, 2017; 135(21): 2003-2012.

WARRAICH HJ, et al. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. American Heart Journal, 2019; 213:91-96.

YAU TM, et al. Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial. JAMA, 2019; 321(12):1176-1186.



  • There are currently no refbacks.